The ERA-EDTA registry annual report 2017: A summary

Anneke Kramer; Rianne Boenink; Marlies Noordzij; Jizzo R. Bosdriesz; Vianda S. Stel; Palma Beltrán; Juan C. Ruiz; Nurhan Seyahi; Jordi Comas Farnés; Maria Stendahl; Liliana Garneata; Rebecca Winzeler; Eliezer Golan; František Lopot; Grzegorz Korejwo; Marjolein Bonthuis; Mathilde Lassalle; Maria F. Slon Roblero; Viktorija Kuzema; Kristine Hommel; Olivera Stojceva-Taneva; Anders Asberg; Reinhard Kramar; Marc H. Hemmelder; Johan de Meester; Evgueniy Vazelov; Anton Andrusev; Pablo Castro de la Nuez; Jaakko Helve; Kirill Komissarov; Anna Casula; Ángela Magaz; Carmen Santiuste de Pablos; Ivan Bubic; Jamie P. Traynor; Kyriakos Ioannou; Alma Idrizi; Runólfur Pálsson; Jean Marin des Grottes; Viera Spustova; Miloreta Tolaj-Avdiu; Faical Jarraya; Maurizio Nordio; Edita Ziginskiene; Ziad A. Massy; Kitty J. Jager; Ivan Bubić

doi:10.1093/CKJ/SFAA048

The ERA-EDTA registry annual report 2017: A summary

Anneke Kramer
, Rianne Boenink
, Marlies Noordzij
, Jizzo R. Bosdriesz
, Vianda S. Stel
, Palma Beltrán
, Juan C. Ruiz
, Nurhan Seyahi
, Jordi Comas Farnés
, Maria Stendahl
, Liliana Garneata
, Rebecca Winzeler
, Eliezer Golan
, František Lopot
, Grzegorz Korejwo
, Marjolein Bonthuis
, Mathilde Lassalle
, Maria F. Slon Roblero
, Viktorija Kuzema
, Kristine Hommel

Olivera Stojceva-Taneva, Anders Asberg, Reinhard Kramar, Marc H. Hemmelder, Johan de Meester, Evgueniy Vazelov, Anton Andrusev, Pablo Castro de la Nuez, Jaakko Helve, Kirill Komissarov, Anna Casula, Ángela Magaz, Carmen Santiuste de Pablos, Ivan Bubic, Jamie P. Traynor, Kyriakos Ioannou, Alma Idrizi, Runólfur Pálsson, Jean Marin des Grottes, Viera Spustova, Miloreta Tolaj-Avdiu, Faical Jarraya, Maurizio Nordio, Edita Ziginskiene, Ziad A. Massy, Kitty J. Jager, Ivan Bubić

University of Iceland, Landspitali

Research output: Contribution to journal › Article › peer-review

Abstract

Background. This article presents a summary of the 2017 Annual Report of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry and describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 37 countries. Methods. The ERA-EDTA Registry received individual patient data on patients undergoing RRT for ESRD in 2017 from 32 national or regional renal registries and aggregated data from 21 registries. The incidence and prevalence of RRT, kidney transplantation activity and survival probabilities of these patients were calculated. Results. In 2017, the ERA-EDTA Registry covered a general population of 694 million people. The incidence of RRT for ESRD was 127 per million population (pmp), ranging from 37 pmp in Ukraine to 252 pmp in Greece. A total of 62% of patients were men, 52% were ≥65 years of age and 23% had diabetes mellitus as the primary renal disease. The treatment modality at the onset of RRT was haemodialysis for 85% of patients. On 31 December 2017, the prevalence of RRT was 854 pmp, ranging from 210 pmp in Ukraine to 1965 pmp in Portugal. The transplant rate in 2017 was 33 pmp, ranging from 3 pmp in Ukraine to 103 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2008-12, the unadjusted 5-year patient survival probability for all RRT modalities combined was 50.8%.

Original language	English
Pages (from-to)	693-709
Number of pages	17
Journal	Clinical Kidney Journal
Volume	13
Issue number	4
DOIs	https://doi.org/10.1093/CKJ/SFAA048
Publication status	Published - 22 Jun 2020

Bibliographical note

The ERA-EDTA Registry is funded by the ERA-EDTA. This article was written by Kramer et al. on behalf of the ERA-EDTA Registry, which is an official body of the ERA-EDTA. In addition, M.F.S.R. reports personal fees from NxStage outside the submitted work and K.J.J. reports grants from the ERA-EDTA during the conduct of the study and a speaker fee from Fresenius Medical Care outside the submitted work. Publisher Copyright: © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Other keywords

Dialysis
End-stage renal disease
Epidemiology
Kidney transplantation
Nýrnabilun
Nýrnalækningar
Renal Replacement Therapy
Survival analysis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/CKJ/SFAA048

Cite this

Kramer, A., Boenink, R., Noordzij, M., Bosdriesz, J. R., Stel, V. S., Beltrán, P., Ruiz, J. C., Seyahi, N., Farnés, J. C., Stendahl, M., Garneata, L., Winzeler, R., Golan, E., Lopot, F., Korejwo, G., Bonthuis, M., Lassalle, M., Slon Roblero, M. F., Kuzema, V., ... Bubić, I. (2020). The ERA-EDTA registry annual report 2017: A summary. Clinical Kidney Journal, 13(4), 693-709. https://doi.org/10.1093/CKJ/SFAA048

@article{bd7bedef57634029957188243181a2e3,

title = "The ERA-EDTA registry annual report 2017: A summary",

abstract = "Background. This article presents a summary of the 2017 Annual Report of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry and describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 37 countries. Methods. The ERA-EDTA Registry received individual patient data on patients undergoing RRT for ESRD in 2017 from 32 national or regional renal registries and aggregated data from 21 registries. The incidence and prevalence of RRT, kidney transplantation activity and survival probabilities of these patients were calculated. Results. In 2017, the ERA-EDTA Registry covered a general population of 694 million people. The incidence of RRT for ESRD was 127 per million population (pmp), ranging from 37 pmp in Ukraine to 252 pmp in Greece. A total of 62\% of patients were men, 52\% were ≥65 years of age and 23\% had diabetes mellitus as the primary renal disease. The treatment modality at the onset of RRT was haemodialysis for 85\% of patients. On 31 December 2017, the prevalence of RRT was 854 pmp, ranging from 210 pmp in Ukraine to 1965 pmp in Portugal. The transplant rate in 2017 was 33 pmp, ranging from 3 pmp in Ukraine to 103 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2008-12, the unadjusted 5-year patient survival probability for all RRT modalities combined was 50.8\%.",

keywords = "N{\'y}rnabilun, N{\'y}rnal{\ae}kningar, Renal Replacement Therapy, dialysis, end-stage renal disease, epidemiology, kidney transplantation, survival analysis, Dialysis, End-stage renal disease, Epidemiology, Kidney transplantation, N{\'y}rnabilun, N{\'y}rnal{\ae}kningar, Renal Replacement Therapy, Survival analysis",

author = "Anneke Kramer and Rianne Boenink and Marlies Noordzij and Bosdriesz, \{Jizzo R.\} and Stel, \{Vianda S.\} and Palma Beltr{\'a}n and Ruiz, \{Juan C.\} and Nurhan Seyahi and Farn{\'e}s, \{Jordi Comas\} and Maria Stendahl and Liliana Garneata and Rebecca Winzeler and Eliezer Golan and Franti{\v s}ek Lopot and Grzegorz Korejwo and Marjolein Bonthuis and Mathilde Lassalle and \{Slon Roblero\}, \{Maria F.\} and Viktorija Kuzema and Kristine Hommel and Olivera Stojceva-Taneva and Anders Asberg and Reinhard Kramar and Hemmelder, \{Marc H.\} and \{de Meester\}, Johan and Evgueniy Vazelov and Anton Andrusev and \{de la Nuez\}, \{Pablo Castro\} and Jaakko Helve and Kirill Komissarov and Anna Casula and {\'A}ngela Magaz and \{de Pablos\}, \{Carmen Santiuste\} and Ivan Bubic and Traynor, \{Jamie P.\} and Kyriakos Ioannou and Alma Idrizi and Run{\'o}lfur P{\'a}lsson and \{des Grottes\}, \{Jean Marin\} and Viera Spustova and Miloreta Tolaj-Avdiu and Faical Jarraya and Maurizio Nordio and Edita Ziginskiene and Massy, \{Ziad A.\} and Jager, \{Kitty J.\} and Ivan Bubi{\'c}",

note = "The ERA-EDTA Registry is funded by the ERA-EDTA. This article was written by Kramer et al. on behalf of the ERA-EDTA Registry, which is an official body of the ERA-EDTA. In addition, M.F.S.R. reports personal fees from NxStage outside the submitted work and K.J.J. reports grants from the ERA-EDTA during the conduct of the study and a speaker fee from Fresenius Medical Care outside the submitted work. Publisher Copyright: {\textcopyright} The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2020",

month = jun,

day = "22",

doi = "10.1093/CKJ/SFAA048",

language = "English",

volume = "13",

pages = "693--709",

journal = "Clinical Kidney Journal",

issn = "2048-8505",

publisher = "Oxford University Press",

number = "4",

}

Kramer, A, Boenink, R, Noordzij, M, Bosdriesz, JR, Stel, VS, Beltrán, P, Ruiz, JC, Seyahi, N, Farnés, JC, Stendahl, M, Garneata, L, Winzeler, R, Golan, E, Lopot, F, Korejwo, G, Bonthuis, M, Lassalle, M, Slon Roblero, MF, Kuzema, V, Hommel, K, Stojceva-Taneva, O, Asberg, A, Kramar, R, Hemmelder, MH, de Meester, J, Vazelov, E, Andrusev, A, de la Nuez, PC, Helve, J, Komissarov, K, Casula, A, Magaz, Á, de Pablos, CS, Bubic, I, Traynor, JP, Ioannou, K, Idrizi, A, Pálsson, R, des Grottes, JM, Spustova, V, Tolaj-Avdiu, M, Jarraya, F, Nordio, M, Ziginskiene, E, Massy, ZA, Jager, KJ & Bubić, I 2020, 'The ERA-EDTA registry annual report 2017: A summary', Clinical Kidney Journal, vol. 13, no. 4, pp. 693-709. https://doi.org/10.1093/CKJ/SFAA048

TY - JOUR

T1 - The ERA-EDTA registry annual report 2017

T2 - A summary

AU - Kramer, Anneke

AU - Boenink, Rianne

AU - Noordzij, Marlies

AU - Bosdriesz, Jizzo R.

AU - Stel, Vianda S.

AU - Beltrán, Palma

AU - Ruiz, Juan C.

AU - Seyahi, Nurhan

AU - Farnés, Jordi Comas

AU - Stendahl, Maria

AU - Garneata, Liliana

AU - Winzeler, Rebecca

AU - Golan, Eliezer

AU - Lopot, František

AU - Korejwo, Grzegorz

AU - Bonthuis, Marjolein

AU - Lassalle, Mathilde

AU - Slon Roblero, Maria F.

AU - Kuzema, Viktorija

AU - Hommel, Kristine

AU - Stojceva-Taneva, Olivera

AU - Asberg, Anders

AU - Kramar, Reinhard

AU - Hemmelder, Marc H.

AU - de Meester, Johan

AU - Vazelov, Evgueniy

AU - Andrusev, Anton

AU - de la Nuez, Pablo Castro

AU - Helve, Jaakko

AU - Komissarov, Kirill

AU - Casula, Anna

AU - Magaz, Ángela

AU - de Pablos, Carmen Santiuste

AU - Bubic, Ivan

AU - Traynor, Jamie P.

AU - Ioannou, Kyriakos

AU - Idrizi, Alma

AU - Pálsson, Runólfur

AU - des Grottes, Jean Marin

AU - Spustova, Viera

AU - Tolaj-Avdiu, Miloreta

AU - Jarraya, Faical

AU - Nordio, Maurizio

AU - Ziginskiene, Edita

AU - Massy, Ziad A.

AU - Jager, Kitty J.

AU - Bubić, Ivan

N1 - The ERA-EDTA Registry is funded by the ERA-EDTA. This article was written by Kramer et al. on behalf of the ERA-EDTA Registry, which is an official body of the ERA-EDTA. In addition, M.F.S.R. reports personal fees from NxStage outside the submitted work and K.J.J. reports grants from the ERA-EDTA during the conduct of the study and a speaker fee from Fresenius Medical Care outside the submitted work. Publisher Copyright: © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2020/6/22

Y1 - 2020/6/22

N2 - Background. This article presents a summary of the 2017 Annual Report of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry and describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 37 countries. Methods. The ERA-EDTA Registry received individual patient data on patients undergoing RRT for ESRD in 2017 from 32 national or regional renal registries and aggregated data from 21 registries. The incidence and prevalence of RRT, kidney transplantation activity and survival probabilities of these patients were calculated. Results. In 2017, the ERA-EDTA Registry covered a general population of 694 million people. The incidence of RRT for ESRD was 127 per million population (pmp), ranging from 37 pmp in Ukraine to 252 pmp in Greece. A total of 62% of patients were men, 52% were ≥65 years of age and 23% had diabetes mellitus as the primary renal disease. The treatment modality at the onset of RRT was haemodialysis for 85% of patients. On 31 December 2017, the prevalence of RRT was 854 pmp, ranging from 210 pmp in Ukraine to 1965 pmp in Portugal. The transplant rate in 2017 was 33 pmp, ranging from 3 pmp in Ukraine to 103 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2008-12, the unadjusted 5-year patient survival probability for all RRT modalities combined was 50.8%.

AB - Background. This article presents a summary of the 2017 Annual Report of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry and describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 37 countries. Methods. The ERA-EDTA Registry received individual patient data on patients undergoing RRT for ESRD in 2017 from 32 national or regional renal registries and aggregated data from 21 registries. The incidence and prevalence of RRT, kidney transplantation activity and survival probabilities of these patients were calculated. Results. In 2017, the ERA-EDTA Registry covered a general population of 694 million people. The incidence of RRT for ESRD was 127 per million population (pmp), ranging from 37 pmp in Ukraine to 252 pmp in Greece. A total of 62% of patients were men, 52% were ≥65 years of age and 23% had diabetes mellitus as the primary renal disease. The treatment modality at the onset of RRT was haemodialysis for 85% of patients. On 31 December 2017, the prevalence of RRT was 854 pmp, ranging from 210 pmp in Ukraine to 1965 pmp in Portugal. The transplant rate in 2017 was 33 pmp, ranging from 3 pmp in Ukraine to 103 pmp in the Spanish region of Catalonia. For patients commencing RRT during 2008-12, the unadjusted 5-year patient survival probability for all RRT modalities combined was 50.8%.

KW - Nýrnabilun

KW - Nýrnalækningar

KW - Renal Replacement Therapy

KW - dialysis

KW - end-stage renal disease

KW - epidemiology

KW - kidney transplantation

KW - survival analysis

KW - Dialysis

KW - End-stage renal disease

KW - Epidemiology

KW - Kidney transplantation

KW - Nýrnabilun

KW - Nýrnalækningar

KW - Renal Replacement Therapy

KW - Survival analysis

UR - https://www.scopus.com/pages/publications/85090639270

U2 - 10.1093/CKJ/SFAA048

DO - 10.1093/CKJ/SFAA048

M3 - Article

C2 - 32897277

SN - 2048-8505

VL - 13

SP - 693

EP - 709

JO - Clinical Kidney Journal

JF - Clinical Kidney Journal

IS - 4

ER -

The ERA-EDTA registry annual report 2017: A summary

Abstract

Bibliographical note

Other keywords

UN SDGs

Access to Document

Fingerprint

Cite this